General Information of Drug (ID: DMCD1PH)

Drug Name
Cellgram
Indication
Disease Entry ICD 11 Status REF
Liver cirrhosis DB93.1 Phase 3 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
D7IO6J

References

1 ClinicalTrials.gov (NCT04689152) A Multicenter, Randomized, Open-label Phase III Clinical Trial to Evaluate Efficacy and Safety of the Cellgram-LC in Patients With Alcoholic Liver Cirrhosis. U.S.National Institutes of Health.